A process is provided for the preparation of value added chemicals such as ethyl levulinate from a glucose or other sugars, catalyzed by a mixture of a Lewis acid catalyst and a Bronsted acid catalyst.

An ionic liquid additive for lithium-ion battery An ionic liquid for adding to an electrolyte of a lithium-ion battery, the ionic liquid comprises a compound with a dual core structure having the general formula (I): ##STR00001## wherein each of cationic group X.sub.1 and X.sub.2 are heterocyclic aromatic and amine.

Provided is a heterogeneous catalyst for preparing a dicarboxylic acid aromatic heterocyclic compound, the heterogeneous catalyst including an active metal; and a basic metal oxide carrier capable of carrying the active metal and forming a complex by coordinate bonding with the dicarboxylic acid aromatic heterocyclic compound.

Provided is a heterogeneous catalyst for preparing a dicarboxylic acid aromatic heterocyclic compound, the heterogeneous catalyst including an active metal; and a basic metal oxide carrier capable of carrying the active metal and forming a complex by coordinate bonding with the dicarboxylic acid aromatic heterocyclic compound.

Provided herein are benzenesulfonamide derivatives having Formula (III), pharmaceutical compositions comprising said compounds, and method for using said compounds for disrupting proteins/polypeptides, protein/polypeptide function, and for the treatment of diseases through the disruption of proteins or polypeptides involved in the etiology of the disease. Said compounds comprise fluorinated benzene sulfonamide structures.

##STR00001##

The disclosure belongs to the technical field of medicine, and relates to use of a diketone compound in photodynamic therapy or diagnosis. Particularly, the disclosure relates to use of a compound of formula (I), pharmaceutically acceptable salt or ester, prodrug, stereoisomer, hydrate, solvate or crystal form of the compound, metabolite of each of them, or any combination or mixture thereof in preparation of a drug or a reagent. The drug or the reagent is used for photodynamic therapy or photodynamic diagnosis of a disease or is used for skin beauty by means of photodynamic therapy.

##STR00001##

A furan-based surfactant comprising a beta sulphonate head group, a furan and a C10-20 hydrophobic group which is either attached directly to the furan or by way of a linker. A laundry composition or a hand dish wash cleaning composition comprising said surfactant.

A furan-based surfactant comprising a beta sulphonate head group, a furan and a C10-20 hydrophobic group which is either attached directly to the furan or by way of a linker. A laundry composition or a hand dish wash cleaning composition comprising said surfactant.

The invention relates to a process for the production of a mixture of 5-hydroxymethylfurfural and glucose from a feedstock containing fructose in the presence of at least one polar aprotic solvent and of at least one dehydration catalyst, in which process the reaction temperature is less than 90° C.

The invention relates to a process for the production of a mixture of 5-hydroxymethylfurfural and glucose from a feedstock containing fructose in the presence of at least one polar aprotic solvent and of at least one dehydration catalyst, in which process the reaction temperature is less than 90° C.